TriSalus Life Sciences (TLSI) had the highest return between December 7, 2023 and December 15, 2023 by a small-cap US stock, returning 111.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
TriSalus Life Sciences (TLSI) | 12/7/2023 - 12/15/2023 | 111.25% |
MBIA (MBI) | 12/7/2023 - 12/15/2023 | 85.96% |
Gaotu Techedu Inc DRC (GOTU) | 12/7/2023 - 12/15/2023 | 78.76% |
Candel Therapeutics (CADL) | 12/7/2023 - 12/15/2023 | 67.5% |
Monte Rosa Therapeutics (GLUE) | 12/7/2023 - 12/15/2023 | 65.02% |
Bitfarms (BITF) | 12/7/2023 - 12/15/2023 | 58.82% |
DeFi Technologies (DEFT) | 12/7/2023 - 12/15/2023 | 53.68% |
ADC Therapeutics (ADCT) | 12/7/2023 - 12/15/2023 | 50% |
Immix Biopharma (IMMX) | 12/7/2023 - 12/15/2023 | 46.87% |
Compass Pathways (CMPS) | 12/7/2023 - 12/15/2023 | 45.45% |
Better Home & Finance (BETR) | 12/7/2023 - 12/15/2023 | 45.19% |
Solid Biosciences LLC (SLDB) | 12/7/2023 - 12/15/2023 | 44.57% |
Meihua International Medical Technologies (MHUA) | 12/7/2023 - 12/15/2023 | 42.51% |
Lendingtree (TREE) | 12/7/2023 - 12/15/2023 | 41.78% |
Loandepot (LDI) | 12/7/2023 - 12/15/2023 | 38.61% |
Priority Technology (PRTH) | 12/7/2023 - 12/15/2023 | 38.44% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/7/2023 - 12/15/2023 | 37.43% |
Blend Labs (BLND) | 12/7/2023 - 12/15/2023 | 35.67% |
Re Max (RMAX) | 12/7/2023 - 12/15/2023 | 35.08% |
AXT (AXTI) | 12/7/2023 - 12/15/2023 | 34.33% |
Cerus (CERS) | 12/7/2023 - 12/15/2023 | 32.92% |
Twist Bioscience (TWST) | 12/7/2023 - 12/15/2023 | 32.61% |
Gyre Therapeutics (GYRE) | 12/7/2023 - 12/15/2023 | 32.54% |
Organogenesis (ORGO) | 12/7/2023 - 12/15/2023 | 31.12% |
First Foundation (FFWM) | 12/7/2023 - 12/15/2023 | 30.72% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
